# Effects of BMS-986256 at Steady State on the Single Dose Pharmacokinetics of Mycophenolate Mofetil

> **NCT04039373** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 15 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** BMS-986256
- **DRUG:** Mycophenolate Mofetil

## Key facts

- **NCT ID:** NCT04039373
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-22
- **Primary completion:** 2019-09-18
- **Final completion:** 2019-10-16
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2020-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04039373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04039373, "Effects of BMS-986256 at Steady State on the Single Dose Pharmacokinetics of Mycophenolate Mofetil". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04039373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*